gms | German Medical Science

61st Annual Meeting of the German Society of Neurosurgery (DGNC) as part of the Neurowoche 2010
Joint Meeting with the Brazilian Society of Neurosurgery on the 20 September 2010

German Society of Neurosurgery (DGNC)

21 - 25 September 2010, Mannheim

O-(2-18F-fluoroethyl)-L-tyrosine (FET) uptake kinetic with parametric mapping is superior in predicting tumor grade in gliomas

Meeting Abstract

  • Christian Ewelt - Klinik für Neurochirurgie, Westfälische Wilhelms Universität, Münster, Deutschland; Klinik für Neurochirurgie, Heinrich Heine Universität, Düsseldorf, Deutschland
  • Marion Rapp - Klinik für Neurochirurgie, Heinrich Heine Universität, Düsseldorf, Deutschland
  • Walter Stummer - Klinik für Neurochirurgie, Westfälische Wilhelms Universität, Münster, Deutschland
  • Michael Sabel - Klinik für Neurochirurgie, Heinrich Heine Universität, Düsseldorf, Deutschland
  • Karl-Josef Langen - Institut für Neurowissenschaften, Forschungszentrum Jülich, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 61. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) im Rahmen der Neurowoche 2010. Mannheim, 21.-25.09.2010. Düsseldorf: German Medical Science GMS Publishing House; 2010. DocV1538

DOI: 10.3205/10dgnc015, URN: urn:nbn:de:0183-10dgnc0152

Published: September 16, 2010

© 2010 Ewelt et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Objective: Treatment and prognosis of gliomas depends on tumor grade. We investigated whether extended analyses of O-(2-18F-fluoroethyl)-L-tyrosine (FET) uptake kinetics provide results superior to those of standard tumor-to-background ratios in predicting tumor grade in glioma patients.

Methods: For standard evaluation areas of FET uptake with a lesion/brain ratio of 1.6 or more were considered indicators of tumor in 120 patients. For dynamic evaluation, maximum of FET uptake in lesion in relation to normal brain tissue were determined for each time frame (0–40 min post-injection). Results were correlated with histopathological findings from PET-guided biopsies – either obtained stereotactically or during resection – and MRI findings. Overall survival (OAS) was determined and correlated with FET kinetics.

Results: Histology revealed gliomas in all patients. Standard evaluation demonstrated a statistically significant difference (p=0.0014) between low (LGG) (n=42; mean lesion/brain tissue ratio of FET uptake: 1.453±0.538) and high grade gliomas (HGG) (n=78; mean lesion/brain tissue ratio of FET uptake 2.323±0.754). Time activity curves showed slight increase in LGG, whereas HGG presented with an early peak (0–20 min) followed by a decrease. Dynamic evaluation successfully separated LGG from HGG with high diagnostic accuracy (sensitivity 96%/specificity 96%). OAS was significantly lower in the group of FET kinetic supposed and histologically confirmed HGG.

Conclusions: This study shows significant differences in the dynamics of FET uptake between low and high grade gliomas. Therefore, parameters addressing the different kinetic pattern allow discrimination with high diagnostic power between these prognostically different groups.